Allergy and immunology


Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine


Emergency medicine




Evidence-based medicine



Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics



Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine



Organisation of health care

Otolaryngology / head and neck surgery


Palliative care


Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy


Public health

Quality of care


Rehabilitation medicine

Renal medicine

Respiratory medicine


Sexual medicine

Sports medicine

Statistics and research methods



Travel medicine


Ops! No article found. Reset filter

Vulnerability to relapse under stress: insights from affective neuroscience

Review article: Biomedical intelligence
Pool ER, Sander D
Swiss Med Wkly. 2019;149:w20151

Decades of research in affective neuroscience have been devoted to identifying the underlying neuropsychological mechanisms that can lead to compulsive reward-seeking behaviours where the amount of effort mobilised to obtain an outcome is no longer justified by its value.

Interventional psychiatry in the management of behavioural and psychological symptoms of dementia: a qualitative review

Review article: Biomedical intelligence
Swierkosz-Lenart K, Mall JF, von Gunten A
Swiss Med Wkly. 2019;149:w20140

Pharmaceutical options for the treatment of behavioural and psychological symptoms of dementia (BPSD) are limited. This article invetigates the potential role of interventional techniques, considering the possible overlapping role of specific neurocircuits underlying BPSD.

Acute effects of lysergic acid diethylamide (LSD) on resting brain function

Review article: Biomedical intelligence
Müller F, Borgwardt S
Swiss Med Wkly. 2019;149:w20124

In recent years, there has been a revival in research on hallucinogenic drugs. One of the most interesting questions is how the typical effects of LSD are represented on a neuronal level. This question was recently addressed by three clinical trials.

Extracellular matrix: a new player in memory maintenance and psychiatric disorders

Review article: Biomedical intelligence
Bach D, Brown SA, Kleim B, Tyagarajan S
Swiss Med Wkly. 2019;149:w20060

Significant strides have been made in developing and refining psychotherapeutic treatments. However, there is significant room to improve them, and they may benefit from innovations such as extracellular matrix modification.

Designing artificial senses: steps from physiology to clinical implementation

Review article: Biomedical intelligence
Pérez Fornos A, Van de Berg R, Sommerhalder J, Guinand N
Swiss Med Wkly. 2019;149:w20061

The goal of this review is to highlight the multiple challenges involved in the development of sensory neuroprostheses, the current state of the technology, and to briefly discuss future clinical and research prospects.

Management of brainstem haemorrhages

Review article: Biomedical intelligence
Wang SS, Yang Y, Velz J, Keller E, Luft AR, Regli L, Neidert MC, Bozinov O
Swiss Med Wkly. 2019;149:w20062

Primary brainstem haemorrhages remain associated with poor outcomes compared to other forms of spontaneous intracranial haemorrhage. Their management needs re-evaluation and reinvestigation to update the relevant data.

Dementia care: the view from general practice

Foley T
Swiss Med Wkly. 2018;148:w20003

Now in Swiss Medical Weekly, dementia care in general practice is examined from the perspective of GPs. The study by Giezendanner et al. is important, shining a light on an increasingly pressing area of primary care and identifying gaps in knowledge, confidence and healthcare services.

A digitally facilitated citizen-science driven approach accelerates participant recruitment and increases study population diversity

Original article
Puhan MA, Steinemann N, Kamm CP, Müller S, Kuhle J, Kurmann R, Calabrese P, Kesselring J, von Wyl V, Swiss Multiple Sclerosis Registry (SMSR)
Swiss Med Wkly. 2018;148:w14623

Conventional clinical studies have a number of shortcomings such as restictive exclusion criteria and failure to address patient-relevant outcomes. Recent developments in society and technology could help to overcome some of these problems.

The role of molecular imaging in assessing degenerative parkinsonism – an updated review

Review article: Biomedical intelligence
Nicastro N, Garibotto V, Burkhard PR
Swiss Med Wkly. 2018;148:w14621

Atypical parkinsonian syndromes are characterised by a modest or nonexistent response to dopaminergic therapy and a poor prognosis, with selective neuronal loss in distinct brain regions that differ from those involved in of Parkinson’s disease.

A ten-year follow-up study of treatment outcome of craniopharyngiomas

Original article
Andereggen L, Hess B, Andres R, El-Koussy M, Mariani L, Raabe A, Seiler RW, Christ E
Swiss Med Wkly. 2018;148:w14521

Craniopharyngioma-related hypothalamic obesity is a devastating complication. There is limited data on whether long-term follow-up of craniopharyngioma patients should focus on problems other than endocrine deficiencies and weight gain.

Verpassen Sie keinen Artikel!